Why Alamar Biosciences Inc (ALMR) Stock Is Rising

As of 2026-10-21, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 49.13%. Featured in our EPS revision report on 2026-10-21.

↑
Detected 2026-10-14: 45.32% → 49.13%
First flagged by our EPS-revision screen

Why ALMR Stock Is Rising

  • +
    EPS Estimate Upgraded: Analysts raised Alamar Biosciences Inc's next-year EPS growth estimate from 45.32% to 49.13% on 2026-10-14.
  • ·
    Current-Year Growth: Projected at -455.49%, supporting the forward estimate revision.

News Context

ALMR stock has been rising primarily after analysts raised the next-year EPS growth estimate to 49.13% from 45.32% on 2026-10-14, a 3.81 percentage-point increase. No recent news headlines are available to identify a specific earnings beat, contract win, guidance raise, or product launch behind the revision. The available data show the upgrade but do not indicate whether momentum continued beyond that initial revision.

Generated 2026-10-21 · news as of 2026-10-21

Current Snapshot

Sector
Healthcare
Industry
Medical Devices
EPS growth next year
49.13%
EPS growth this year
-455.49%
EPS next quarter (est)
-$0.20
Last price
$30.79

EPS Revision History

49.1%45.3%09-2109-2810-0610-1310-21
Next-year EPS growth estimate · latest 30 days · 28 observations
-406.4%-434.7%09-2109-2810-0610-1310-21
Combined EPS growth (this year + next year) · latest 30 days · 28 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-10-2149.13%-455.49%-$0.20$30.79
2026-10-2049.13%-455.49%-$0.20$28.16
2026-10-1949.13%-455.49%-$0.20$26.30
2026-10-1649.13%-455.49%-$0.20$25.28
2026-10-1549.13%-455.49%-$0.20$27.42
2026-10-1449.13%-455.49%-$0.20$25.37
2026-10-1345.32%-480.00%-$0.21$23.52
2026-10-1245.32%-480.00%-$0.21$24.24
2026-10-1145.32%-480.00%-$0.21$25.27
2026-10-1045.32%-480.00%-$0.21$25.27
2026-10-0945.32%-480.00%-$0.21$25.27
2026-10-0845.32%-480.00%-$0.21$25.91
2026-10-0745.32%-480.00%-$0.21$27.77
2026-10-0645.32%-480.00%-$0.21$32.26
2026-10-0545.32%-480.00%-$0.21$38.13
2026-10-0445.32%-480.00%-$0.21$34.36
2026-10-0345.32%-480.00%-$0.21$34.36
2026-10-0245.32%-480.00%-$0.21$34.36
2026-10-0145.32%-480.00%-$0.21$32.46
2026-09-3045.32%-480.00%-$0.21$34.07
2026-09-2945.32%-480.00%-$0.21$32.65
2026-09-2845.32%-480.00%-$0.21$32.61
2026-09-2745.32%-480.00%-$0.21$32.80
2026-09-2545.32%-480.00%-$0.21$32.80
2026-09-2445.32%-480.00%-$0.21$33.20
2026-09-2345.32%-480.00%-$0.21$32.14
2026-09-2245.32%-480.00%-$0.21$33.22
2026-09-2145.32%-480.00%-$0.21$35.05
2026-09-2045.32%-480.00%-$0.21$34.85
2026-09-1845.32%-480.00%-$0.21$34.85

Reports Featuring ALMR

Screen Performance

Aggregate stats across all 2088 tickers our top-EPS-revision screen has flagged over the past 203 days.

Median return since detection
-2.0%
% of tickers in the green
45%
Median return on winners
+22.6%
Large revisions captured
1915

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Also Tracked by Our Screen

Frequently Asked Questions

Why did Alamar Biosciences Inc (ALMR) stock go up recently?▾

Alamar Biosciences Inc (ALMR) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 45.32% to 49.13% on 2026-10-14. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.

What is Alamar Biosciences Inc's next-year EPS growth estimate?▾

As of 2026-10-21, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 49.13%, based on analyst consensus.

When was the latest EPS estimate revision for ALMR?▾

The most recent revision occurred on 2026-10-14, when analysts adjusted the next-year EPS growth estimate from 45.32% to 49.13%.

What sector and industry does Alamar Biosciences Inc belong to?▾

Alamar Biosciences Inc operates in the Healthcare sector, specifically the Medical Devices industry.

How often is this EPS estimate data updated?▾

EPS revision data is refreshed daily from analyst consensus estimates. ALMR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Alamar Biosciences Inc (ALMR) appears here because it was detected by our daily top-EPS-revision-performer screen.